DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,649,869 | +6.1% | 22,773 | +2.6% | 0.35% | +3.6% |
| Q2 2023 | $5,324,963 | +16.3% | 22,187 | +22.2% | 0.34% | +10.1% |
| Q1 2023 | $4,576,835 | -5.2% | 18,159 | -0.2% | 0.31% | -8.9% |
| Q4 2022 | $4,828,788 | +9.7% | 18,193 | +6.8% | 0.34% | -8.4% |
| Q3 2022 | $4,400,000 | +10.8% | 17,035 | +8.7% | 0.37% | +5.5% |
| Q2 2022 | $3,972,000 | -5.9% | 15,667 | +8.8% | 0.35% | -3.6% |
| Q1 2022 | $4,223,000 | -17.0% | 14,396 | -6.9% | 0.36% | -21.4% |
| Q4 2021 | $5,087,000 | +27.5% | 15,460 | +18.0% | 0.46% | +13.1% |
| Q3 2021 | $3,990,000 | +2.7% | 13,106 | -9.5% | 0.41% | -4.5% |
| Q2 2021 | $3,886,000 | +69.0% | 14,481 | +41.8% | 0.42% | +32.8% |
| Q1 2021 | $2,299,000 | +39.2% | 10,214 | +37.3% | 0.32% | +4.2% |
| Q4 2020 | $1,652,000 | +89.9% | 7,439 | +84.1% | 0.31% | +59.1% |
| Q3 2020 | $870,000 | +40.3% | 4,040 | +15.3% | 0.19% | +32.2% |
| Q2 2020 | $620,000 | +53.5% | 3,504 | +20.0% | 0.15% | +32.7% |
| Q1 2020 | $404,000 | +14.8% | 2,921 | +27.4% | 0.11% | -1.8% |
| Q4 2019 | $352,000 | +11.0% | 2,292 | +4.4% | 0.11% | -28.2% |
| Q3 2019 | $317,000 | +7.5% | 2,195 | +6.2% | 0.16% | -12.4% |
| Q2 2019 | $295,000 | +31.1% | 2,066 | +21.0% | 0.18% | +63.3% |
| Q1 2019 | $225,000 | +59.6% | 1,708 | +24.9% | 0.11% | +55.7% |
| Q4 2018 | $141,000 | +2.2% | 1,368 | +8.1% | 0.07% | -12.5% |
| Q3 2018 | $138,000 | +16.9% | 1,266 | +5.9% | 0.08% | +11.1% |
| Q2 2018 | $118,000 | +12.4% | 1,196 | +13.0% | 0.07% | +18.0% |
| Q1 2018 | $105,000 | +26.5% | 1,058 | +17.8% | 0.06% | +15.1% |
| Q4 2017 | $83,000 | +13.7% | 898 | +6.5% | 0.05% | -1.9% |
| Q3 2017 | $73,000 | – | 843 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |